Latest Trustworthy News from Dr. Mercola - delivered straight to your inbox!

Is the RSV Shot Worth the Risk to Your Baby?

Analysis by Dr. Joseph Mercola

infant rsv shot nirsevimab

Story at-a-glance

  • Nirsevimab, a new RSV shot for infants, has raised safety concerns after reports of infant deaths following administration. The reporting system for adverse events is unclear, potentially leading to underreporting

Top

By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Service.